Polypeptide, immunogenicity conjugate and influenza vaccine
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 华兰生物疫苗股份有限公司
- Publication Date
- 2017-12-19
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of biotechnology, in particular to a polypeptide, an immunogenic conjugate and an influenza vaccine. Background technique
[0002] Influenza A virus is a common influenza virus. Influenza A virus is the most likely to mutate. The subtype of influenza A virus is called "bird flu". Bird flu (Bird Flu) is caused by bird flu virus. Acute infectious disease, virus gene mutation can infect human beings, the main symptoms after infection are high fever, cough, runny nose, myalgia, etc. Most of them are accompanied by severe pneumonia. In severe cases, heart, kidney and other organ failure lead to death , the fatality rate is high. Influenza A is highly pathogenic to humans and has caused worldwide pandemics many times. Among the influenza A viruses, the subtypes of avian influenza viruses that can directly infect humans have been found so far: A H1N1, H5N1, H7N1, H7N2, H7N3, H7N7, H7N9, H9N2 and H10N8. Among the...